Actinium Pharmaceuticals
ATNM
#10611
Rank
โ‚น2.38 B
Marketcap
โ‚น75.91
Share price
1.32%
Change (1 day)
-43.63%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2026 (TTM): -โ‚น2.28 Billion

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are โ‚น0.09 Million. In 2025 the company made an earning of -โ‚น3.46 Billion, an increase over its 2024 earnings that were of -โ‚น4.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น2.28 Billion-34.03%
2025 -โ‚น3.46 Billion-13.95%
2024 -โ‚น4.01 Billion-18.87%
2023 -โ‚น4.95 Billion52.24%
2022 -โ‚น3.25 Billion36.61%
2021 -โ‚น2.38 Billion11.48%
2020 -โ‚น2.14 Billion1.46%
2019 -โ‚น2.11 Billion-7.37%
2018 -โ‚น2.27 Billion-11.46%
2017 -โ‚น2.57 Billion10.67%
2016 -โ‚น2.32 Billion15.7%
2015 -โ‚น2.01 Billion-14.86%
2014 -โ‚น2.36 Billion129.19%
2013 -โ‚น1.03 Billion-8.55%
2012 -โ‚น1.13 Billion
2010 โ‚น0.78 M-152.15%
2009 -โ‚น1.52 Million-39.8%
2008 -โ‚น2.52 Million120.29%
2007 -โ‚น1.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-โ‚น3.55 Billion 45.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น18.18 M-100.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น36.70 B-1,611.42%๐Ÿ‡บ๐Ÿ‡ธ USA